# Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets

> **NCT02078284** · PHASE1 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 28 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **BIOLOGICAL:** CPP
- **BIOLOGICAL:** LSP

## Key facts

- **NCT ID:** NCT02078284
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-07-17
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078284, "Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02078284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*